VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Pharmaceutical
Werner Baumann, management board chairman at German pharma and crop sciences major Bayer, is confident that the company can deliver after raising the combined peak annual sales potential of five recently launched pharmaceutical products by a third. 20 September 2016
Pharmaceutical
In our weekly expert view piece, Michael Jewell, healthcare partner at Cavendish Corporate Finance, explains why we can expect mid-market companies to press on with their expansion through strategic transactions for the remainder of 2016. 20 September 2016
Biotechnology
Belgian drugmaker Ablynx has posted 2016 half-yearly financial results showing its revenue and grant income rose by 39% compared to 2015’s first six months. 25 August 2016
Generics
Hikma Pharmaceuticals saw its profits drop by 14% in the first half of 2016 compared to last year, but the Jordan-based drugmaker has reiterated its full year revenue guidance. 24 August 2016
Generics
Canada's battered drugmaker Valeant Pharmaceuticals International has had some good news in the shape of lender consent for an amendment to its credit facility, but it comes in the midst of accusations from its former shareholder T Rowe Price. 22 August 2016
Pharmaceutical
The market for respiratory drugs will grow from its 2015 size of $28.1 billion to $46.6 billion by 2022 at a compound annual growth rate (CAGR) of 7.5%, according to business intelligence provider GBI Research. 18 August 2016
Pharmaceutical
In our weekly expert view piece, Ed Corbett, engagement manager at specialist management consultancy firm Novasecta, explores the different routes British pharma giant GSK might take to ensure its next wave of growth. 18 August 2016
Pharmaceutical
Canada-based drugmaker Valeant Pharmaceuticals' share price soared by more than a quarter on Tuesday – despite missing analyst predictions in its quarterly results. 10 August 2016
Pharmaceutical
It was a grim Monday morning for Ireland-incorporated company Allergan as its share price slid by nearly 3% in early trading after posting quarterly results which did not deliver the revenue returns which analysts expected. 8 August 2016
Pharmaceutical
More than 9% was wiped off the value of Novo Nordisk’s share price on Friday as the Danish diabetes giant reduced its sales and profit estimates for the year. 5 August 2016
Generics
Bosses at Teva Pharmaceutical Industries remain confident in its ability to deliver multi-year growth despite a slight dip in sales in its generics business in this year’s second quarter compared to the same period of 2015. 4 August 2016
Pharmaceutical
German science and technology company Merck KGaA (MRK: DE) reported an 18.2% increase in net sales to 3.8 billion euros ($4.2 billion) in its second quarter results. 4 August 2016
Pharmaceutical
Shares in Anglo-Irish drugmaker Shire Pharmaceuticals rose 2.8% after the company upgraded its profit forecasts on the back of positive second quarter results. 2 August 2016
Pharmaceutical
US pharma giant Pfizer beat earnings expectations with its 2nd-qtr 2016 financial results, but markets responded negatively as its share price dropped by nearly 2.5% to $36.39 in Tuesday morning’s trading. 2 August 2016
Biotechnology
Aptevo Therapeutics has completed its separation from US biotech Emergent BioSolutions to become an independent, publicly traded corporation. 2 August 2016
Pharmaceutical
In our weekly expert view piece, patent attorney and head of life sciences at intellectual property firm Withers & Rogers LLP, Adrian Tombling, examines GSK's decision to invest £275m at three of its UK manufacturing sites. 2 August 2016
Pharmaceutical
US pharma giant Merck & Co has beaten analysts’ predictions in its second quarter revenue total, thanks partly to strong sales of its new cancer drug Keytruda (pembrolizumab) and the diabetes product Januvia (sitagliptin). 29 July 2016
Pharmaceutical
Shares in Spanish drugmaker Grifols declined more than 5% by Friday afternoon versus two days earlier, after the company’s half-year earnings failed to meet market predictions. 29 July 2016
Biotechnology
Shares in US biotech firm Celgene rose more than 2.5% after the company reported a 22% increase in revenue for the second quarter of 2016. 28 July 2016
Biotechnology
US pharma major Bristol-Myers Squibb raised its earnings forecast for 2016 after reporting a 17% increase in second quarter 2016 revenues. 28 July 2016
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze